Peroxisomal Alterations in Prostate Cancer: Metabolic Shifts and Clinical Relevance

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Cancer involves uncontrolled cell proliferation and survival, influenced by metabolic and signaling pathway disruptions.
• While mitochondria and ER roles in cancer are known, peroxisomes' oncogenic involvement is emerging.
• Peroxisomes are vital for lipid metabolism, bile acid synthesis, and redox balance.

Purpose of the Study:

• To review the role of peroxisomes in prostate cancer (PCa) metabolism, progression, and therapeutic response.
• To explore peroxisomes as potential biomarkers and therapeutic targets in PCa.
• To examine the relationship between peroxisomes and androgen receptor signaling in PCa.

Main Methods:

• Literature review of peroxisome involvement in cancer, specifically PCa.
• Analysis of metabolic adaptations in PCa, contrasting with the Warburg effect.
• Examination of key peroxisomal alterations in PCa, including enzyme activity and biomarker expression.

Main Results:

• Primary PCa relies on lipogenesis and oxidative phosphorylation, unlike the Warburg effect.
• Peroxisomal alterations in PCa include increased branched-chain fatty acid oxidation and altered enzyme expression (AMACR upregulation, AGL/CAT downregulation).
• Peroxisomes influence PCa progression and therapy resistance.

Conclusions:

• Peroxisomes are integral to PCa's unique metabolic profile and disease trajectory.
• Targeting peroxisomal pathways presents a promising strategy for novel PCa therapies.
• Further research into peroxisome biology can enhance PCa treatment and patient outcomes.